1190 related articles for article (PubMed ID: 27639844)
41. Replicative and transcriptional activities of hepatitis B virus in patients coinfected with hepatitis B and hepatitis delta viruses.
Pollicino T; Raffa G; Santantonio T; Gaeta GB; Iannello G; Alibrandi A; Squadrito G; Cacciola I; Calvi C; Colucci G; Levrero M; Raimondo G
J Virol; 2011 Jan; 85(1):432-9. PubMed ID: 20962099
[TBL] [Abstract][Full Text] [Related]
42. Serum HBV DNA plus RNA reflecting cccDNA level before and during NAs treatment in HBeAg positive CHB patients.
Wang Y; Liu Y; Liao H; Deng Z; Bian D; Ren Y; Yu G; Jiang Y; Bai L; Liu S; Liu M; Zhou L; Chen Y; Chen X; Duan Z; Lu F; Zheng S
Int J Med Sci; 2022; 19(5):858-866. PubMed ID: 35693741
[No Abstract] [Full Text] [Related]
43. Hepatitis B virus-specific T cell responses after stopping nucleos(t)ide analogue therapy in HBeAg-negative chronic hepatitis B.
Rinker F; Zimmer CL; Höner Zu Siederdissen C; Manns MP; Kraft ARM; Wedemeyer H; Björkström NK; Cornberg M
J Hepatol; 2018 Sep; 69(3):584-593. PubMed ID: 29758333
[TBL] [Abstract][Full Text] [Related]
44. Correlation between intrahepatic hepatitis B virus cccDNA levels and other activity markers in patients with HBeAg-negative chronic hepatitis B infection.
Guner R; Karahocagil M; Buyukberber M; Kandemir O; Ural O; Usluer G; Inan D; Koksal I; Baykam N; Hizel K; Yamazhan T; Esen S; Tasyaran MA
Eur J Gastroenterol Hepatol; 2011 Nov; 23(12):1185-91. PubMed ID: 21934508
[TBL] [Abstract][Full Text] [Related]
45. Review article: hepatitis B core-related antigen (HBcrAg): an emerging marker for chronic hepatitis B virus infection.
Mak LY; Wong DK; Cheung KS; Seto WK; Lai CL; Yuen MF
Aliment Pharmacol Ther; 2018 Jan; 47(1):43-54. PubMed ID: 29035003
[TBL] [Abstract][Full Text] [Related]
46. Correlation between serum hepatitis B virus core-related antigen and intrahepatic covalently closed circular DNA in chronic hepatitis B patients.
Suzuki F; Miyakoshi H; Kobayashi M; Kumada H
J Med Virol; 2009 Jan; 81(1):27-33. PubMed ID: 19031469
[TBL] [Abstract][Full Text] [Related]
47. One-year entecavir or lamivudine therapy results in reduction of hepatitis B virus intrahepatic covalently closed circular DNA levels.
Wong DK; Yuen MF; Ngai VW; Fung J; Lai CL
Antivir Ther; 2006; 11(7):909-16. PubMed ID: 17302253
[TBL] [Abstract][Full Text] [Related]
48. Serum hepatitis B surface antigen correlates with tissue covalently closed circular DNA in patients with hepatitis B-associated hepatocellular carcinoma.
Wang Q; Luan W; Warren L; Fiel MI; Blank S; Kadri H; Tuvin D; Hiotis SP
J Med Virol; 2016 Feb; 88(2):244-51. PubMed ID: 26174662
[TBL] [Abstract][Full Text] [Related]
49. Upcoming pharmacological developments in chronic hepatitis B: can we glimpse a cure on the horizon?
Alonso S; Guerra AR; Carreira L; Ferrer JÁ; Gutiérrez ML; Fernandez-Rodriguez CM
BMC Gastroenterol; 2017 Dec; 17(1):168. PubMed ID: 29268704
[TBL] [Abstract][Full Text] [Related]
50. Integration of hepatitis B virus S gene impacts on hepatitis B surface antigen levels in patients with antiviral therapy.
Hu B; Wang R; Fu J; Su M; Du M; Liu Y; Li H; Wang H; Lu F; Jiang J
J Gastroenterol Hepatol; 2018 Jul; 33(7):1389-1396. PubMed ID: 29266382
[TBL] [Abstract][Full Text] [Related]
51. Intrahepatic hepatitis B virus covalently closed circular DNA can be a predictor of sustained response to therapy.
Sung JJ; Wong ML; Bowden S; Liew CT; Hui AY; Wong VW; Leung NW; Locarnini S; Chan HL
Gastroenterology; 2005 Jun; 128(7):1890-7. PubMed ID: 15940624
[TBL] [Abstract][Full Text] [Related]
52. Duck hepatitis B virus covalently closed circular DNA appears to survive hepatocyte mitosis in the growing liver.
Reaiche-Miller GY; Thorpe M; Low HC; Qiao Q; Scougall CA; Mason WS; Litwin S; Jilbert AR
Virology; 2013 Nov; 446(1-2):357-64. PubMed ID: 24074600
[TBL] [Abstract][Full Text] [Related]
53. Quantification of circulating HBV RNA expressed from intrahepatic cccDNA in untreated and NUC treated patients with chronic hepatitis B.
Testoni B; Scholtès C; Plissonnier ML; Paturel A; Berby F; Facchetti F; Villeret F; Degasperi E; Scott B; Hamilton A; Heil M; Lampertico P; Levrero M; Zoulim F
Gut; 2024 Mar; 73(4):659-667. PubMed ID: 37879886
[TBL] [Abstract][Full Text] [Related]
54. Hepatitis B viral DNA decline at loss of HBeAg is mainly explained by reduced cccDNA load--down-regulated transcription of PgRNA has limited impact.
Malmström S; Larsson SB; Hannoun C; Lindh M
PLoS One; 2012; 7(7):e36349. PubMed ID: 22911677
[TBL] [Abstract][Full Text] [Related]
55. Compartmental HBV evolution and replication in liver and extrahepatic sites after nucleos/tide analogue therapy in chronic hepatitis B carriers.
Gao S; Duan ZP; Chen Y; van der Meer F; Lee SS; Osiowy C; van Marle G; Coffin CS
J Clin Virol; 2017 Sep; 94():8-14. PubMed ID: 28709006
[TBL] [Abstract][Full Text] [Related]
56. Nucleos(t)ide analogues for hepatitis B virus: strategies for long-term success.
Chien RN; Liaw YF
Best Pract Res Clin Gastroenterol; 2008; 22(6):1081-92. PubMed ID: 19187868
[TBL] [Abstract][Full Text] [Related]
57. Decay of ccc-DNA marks persistence of intrahepatic viral DNA synthesis under tenofovir in HIV-HBV co-infected patients.
Boyd A; Lacombe K; Lavocat F; Maylin S; Miailhes P; Lascoux-Combe C; Delaugerre C; Girard PM; Zoulim F
J Hepatol; 2016 Oct; 65(4):683-691. PubMed ID: 27210429
[TBL] [Abstract][Full Text] [Related]
58. Analysis of hepatitis B virus intrahepatic covalently closed circular DNA and serum viral markers in treatment-naive patients with acute and chronic HBV infection.
Li W; Zhao J; Zou Z; Liu Y; Li B; Sun Y; Li X; Liu S; Cai S; Yao W; Xin S; Lu F; Xu D
PLoS One; 2014; 9(2):e89046. PubMed ID: 24551214
[TBL] [Abstract][Full Text] [Related]
59. Quantification of hepatitis B virus covalently closed circular DNA in patients with hepatocellular carcinoma.
Wong DK; Yuen MF; Poon RT; Yuen JC; Fung J; Lai CL
J Hepatol; 2006 Oct; 45(4):553-9. PubMed ID: 16904225
[TBL] [Abstract][Full Text] [Related]
60. Quantification and epigenetic evaluation of the residual pool of hepatitis B covalently closed circular DNA in long-term nucleoside analogue-treated patients.
Lebossé F; Inchauspé A; Locatelli M; Miaglia C; Diederichs A; Fresquet J; Chapus F; Hamed K; Testoni B; Zoulim F
Sci Rep; 2020 Dec; 10(1):21097. PubMed ID: 33273565
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]